NYSE:EWMedical Equipment
Edwards Lifesciences (EW) Stock Faces Margin Hit As One Off Loss Tests Bullish Narratives
Edwards Lifesciences (EW) has reported Q2 2026 results with total revenue of US$1,741 million and basic EPS of US$0.42, while trailing twelve month revenue stands at US$6.5 billion with EPS of US$1.69 as the company works through a period of softer profitability. The company has seen quarterly revenue move from US$1,532 million in Q2 2025 to US$1,741 million in Q2 2026, with basic EPS shifting from US$0.58 to US$0.42 over the same period as trailing net margin compressed from 24.8% to 15% and...